Zimmer Biomet Holdings
ZBH
101.10
-0.37
-0.36%
Zimmer Biomet Holdings
US · ZBH
#1040 by market cap
Listed 1970
101.10
-0.37
-0.36%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Quant vs Street three independent views, side by side
StockVane factor grade
B
Momentum strategy signal
Hold
Analyst consensus
Buy
Mostly aligned, one view stands apart.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
✦ Quant Analyst Revision Trend how this is computed
Mixed
4 3
■ Upgrades■ Downgrades
- 4 upgrades vs 3 downgrades among tracked analyst rating changes.
- Most recent: Wells Fargo moved from Hold to Buy on 2026-11-17.
Analyst consensus 16 analysts
Buy
Avg price target 118.53 +17.2%
Price target rangecurrent 101.10
Low102.00
Avg118.53
High140.00
Buy 31%
Hold 69%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-11-19 | Leerink Partners | -- | Hold | 112.00 |
| 2026-11-17 | Wells Fargo | -- | Buy | 123.00 |
| 2026-11-16 | Stifel | -- | Buy | 140.00 |
| 2026-11-15 | BofA Securities | -- | Hold | 120.00 |
| 2026-11-09 | Piper Sandler | -- | Hold | 110.00 |
| 2026-11-09 | Barclays | -- | Hold | 115.00 |
| 2026-11-05 | CCORF | -- | Hold | 111.00 |
| 2026-11-05 | Wells Fargo | -- | Hold | 113.00 |
| 2026-11-05 | UBS | -- | Buy | 130.00 |
| 2026-11-05 | Truist Financial | -- | Hold | 114.00 |
| 2026-11-05 | Baird | -- | Hold | 114.00 |
| 2026-11-05 | Stifel | -- | Buy | 125.00 |
| 2026-11-05 | Citi | -- | Hold | 117.00 |
| 2026-11-05 | J.P. Morgan | -- | Hold | 120.00 |
| 2026-11-04 | BTIG | -- | Hold | -- |
| 2026-11-04 | BMO Capital | -- | Hold | 102.00 |
| 2026-11-04 | Citi | -- | Hold | 117.00 |
| 2026-11-04 | RBC Capital | -- | Buy | 125.00 |
| 2026-10-21 | Argus Research | -- | Buy | 125.00 |
| 2026-10-12 | Leerink Partners | -- | Hold | 97.00 |
| 2026-10-09 | BTIG | -- | Hold | -- |
| 2026-10-07 | Barclays | -- | Hold | 100.00 |
| 2026-10-05 | Citi | -- | Hold | 99.00 |
| 2026-10-01 | RBC Capital | -- | Buy | 110.00 |
| 2026-09-25 | BofA Securities | -- | Hold | 110.00 |
Price target trend monthly average, last 3 years
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-11-17 | Wells Fargo | Hold → Buy | 123.00 |
| 2026-11-05 | CCORF | Buy → Hold | 111.00 |
| 2026-08-10 | CCORF | Hold → Buy | 100.00 |
| 2026-07-28 | UBS | Sell → Buy | 115.00 |
| 2026-03-23 | BTIG | Buy → Hold | -- |
| 2026-01-05 | Evercore | Hold → Buy | 120.00 |
| 2025-12-16 | Baird | Buy → Hold | 100.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q3 | 2026-11-04 | -- | ±6.38% | +13.49% (beat) |
| 2026/Q2 | 2026-08-05 | -- | ±6.29% | +2.45% (in line) |
| 2026/Q1 | 2026-04-28 | -- | ±5.45% | -10.57% (beat) |
| 2025/Q4 | 2026-02-10 | -- | ±6.83% | +1.86% (in line) |
| 2025/Q3 | 2025-11-05 | -- | ±6.27% | -15.15% (beat) |
| 2025/Q2 | 2025-08-07 | -- | ±10.85% | +7.99% (in line) |
| 2025/Q1 | 2025-05-05 | -- | ±7.28% | -11.62% (beat) |
| 2024/Q4 | 2025-02-06 | -- | ±5.82% | -5.14% (in line) |
| 2024/Q3 | 2024-10-30 | -- | ±8.12% | +5.71% (in line) |
| 2024/Q2 | 2024-08-07 | -- | ±7.04% | -3.43% (in line) |
| 2024/Q1 | 2024-05-02 | -- | ±7.14% | -0.92% (in line) |
| 2023/Q4 | 2024-02-08 | -- | ±5.81% | -3.54% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Zimmer Biomet Holdings discussion 0 comments